Remove 2012 Remove Acquisition Remove Marketing Remove Study
article thumbnail

Evoke Pharma’s Stock Sinks on Stomach Drug’s Phase 3 Failure

Xconomy

Evoke Pharma is taking a hit in the markets after announcing a Phase 3 trial on a gastroinetestinal drug for diabetes patients failed to meet its goals. Evoke’s late-stage study failed to show a significant benefit to the drug, EVK-001, versus placebo at all 41 of the sites that tested it nationally. per share as of 11:30 a.m.

Study 40
article thumbnail

Is Your Startup Ready For The Challenges Of An IPO?

Startup Professionals Musings

IPO market showed more activity than any other first quarter since 2000, with 64 companies raising $10.6 According to a 2012 study by PricewaterhouseCoopers , companies average $3.7 You better have lined up a major international expansion, some major acquisition candidates, or a wealth of unfilled orders.

Startup 94
article thumbnail

How To Strike a Chord with Your Community: Plug.DJ’s Alex Reinlieb

Tech Zulu Event

I’ve been an avid user of Plug.DJ’s music discovery site since early 2012, have discovered a ton of music there (which, by the way, I’m still listening to today) and originally covered their $1.25M in seed-round funding from Javelin Venture Partners. was founded in February 2012 by a team of passionate music fans.

Startup 107